Dr. Hosein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-243-3462Fax+1 305-243-4975
Summary
- I am board certified by the American Board of Internal Medicine in Internal Medicine, Hematology and Medical Oncology. I obtained my medical degree from the University of the West Indies in Trinidad and Tobago. I did my residency in Internal Medicine and fellowship in Hematology/Oncology at the University of Miami/Jackson Memorial Hospital in Miami, Fla. I was formerly a faculty member at the University of Miami/Sylvester Comprehensive Cancer Center prior to coming to the University of Kentucky. My office is located at the Markey Cancer Center where I am a specialist in gastrointestinal cancers and sarcomas. I have conducted and participated in multiple phase I, II and III clinical trials in hematological cancers as well as gastrointestinal cancers.
My main research interest is in pancreatic cancer where I am studying new treatments for patients who are not surgical candidates. I am also conducting research in hepatocellular cancer (primary liver cancer) and gastroesophageal cancers.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2004 - 2007
- University of the West Indies Faculty of MedicineClass of 2001
Certifications & Licensure
- FL State Medical License 2010 - 2026
- KY State Medical License 2014 - 2017
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer Start of enrollment: 2009 Aug 01
- Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma Start of enrollment: 2012 Jul 01
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 158 citationsPercutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinomaGovindarajan Narayanan, Peter J. Hosein, G. Arora, K.J. Barbery, Tatiana Froud
Journal of Vascular and Interventional Radiology. 2012-12-01 - 74 citationsA multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab eraPeter J. Hosein, Jocelyn C. Maragulia, Matthew P Salzberg, Oliver W. Press, Thomas M. Habermann
British Journal of Haematology. 2014-05-01 - 122 citationsPhase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinomaLynn G. Feun, Ying-Ying Li, Chunjing Wu, Medhi Wangpaichitr, Patricia D. Jones
Cancer. 2019-10-15
Press Mentions
- ‘He Took My Call and Saved My Life.’ How Two Men with Pancreatic Cancer Beat the OddsMay 13th, 2022
- Earlier Nab-Paclitaxel/Gemcitabine Explored in Pancreatic CancerMay 17th, 2016
- Oncology Experts Available to Comment on Risk Factors for Melanoma, Pancreatic Cancers in Light of Jimmy Carter DiagnosisFebruary 12th, 2016
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: